Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-trace').style.display = (document.getElementById('cakeErr67f8446b8c949-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f8446b8c949-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-code').style.display = (document.getElementById('cakeErr67f8446b8c949-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-context').style.display = (document.getElementById('cakeErr67f8446b8c949-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f8446b8c949-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f8446b8c949-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6648,
		&#039;title&#039; =&gt; &#039;Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;
&lt;br /&gt;
DR-TB medicines are very expensive&lt;br /&gt;
&lt;br /&gt;
Need to improve access to DR-TB drugs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;
&lt;br /&gt;
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;
&lt;br /&gt;
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;
&lt;br /&gt;
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;
&lt;br /&gt;
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;
&lt;br /&gt;
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;
&lt;br /&gt;
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;
&lt;br /&gt;
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;
&lt;br /&gt;
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;
&lt;br /&gt;
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6744,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6648,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;&lt;br /&gt;DR-TB medicines are very expensive&lt;br /&gt;&lt;br /&gt;Need to improve access to DR-TB drugs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;&lt;br /&gt;The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;&lt;br /&gt;The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;&lt;br /&gt;The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;&lt;br /&gt;The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;&lt;br /&gt;Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;&lt;br /&gt;A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;&lt;br /&gt;The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;&lt;br /&gt;One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;&lt;br /&gt;Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6648,
	&#039;title&#039; =&gt; &#039;Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;
&lt;br /&gt;
DR-TB medicines are very expensive&lt;br /&gt;
&lt;br /&gt;
Need to improve access to DR-TB drugs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;
&lt;br /&gt;
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;
&lt;br /&gt;
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;
&lt;br /&gt;
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;
&lt;br /&gt;
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;
&lt;br /&gt;
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;
&lt;br /&gt;
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;
&lt;br /&gt;
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;
&lt;br /&gt;
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;
&lt;br /&gt;
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6744,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6648
$metaTitle = &#039;LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;&lt;br /&gt;DR-TB medicines are very expensive&lt;br /&gt;&lt;br /&gt;Need to improve access to DR-TB drugs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;&lt;br /&gt;The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;&lt;br /&gt;The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;&lt;br /&gt;The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;&lt;br /&gt;The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;&lt;br /&gt;Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;&lt;br /&gt;A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;&lt;br /&gt;The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;&lt;br /&gt;One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;&lt;br /&gt;Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar | Im4change.org</title>
    <meta name="description" content="
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify"><em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br /><br />DR-TB medicines are very expensive<br /><br />Need to improve access to DR-TB drugs<br /></em><br />As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br /><br />The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br /><br />The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br /><br />The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br /><br />The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br /><br />Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br /><br />&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br /><br />&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br /><br />Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br /><br />A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br /><br />&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br /><br />&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br /><br />The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br /><br />One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br /><br />Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br /><br />&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-trace').style.display = (document.getElementById('cakeErr67f8446b8c949-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f8446b8c949-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-code').style.display = (document.getElementById('cakeErr67f8446b8c949-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-context').style.display = (document.getElementById('cakeErr67f8446b8c949-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f8446b8c949-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f8446b8c949-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6648,
		&#039;title&#039; =&gt; &#039;Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;
&lt;br /&gt;
DR-TB medicines are very expensive&lt;br /&gt;
&lt;br /&gt;
Need to improve access to DR-TB drugs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;
&lt;br /&gt;
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;
&lt;br /&gt;
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;
&lt;br /&gt;
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;
&lt;br /&gt;
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;
&lt;br /&gt;
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;
&lt;br /&gt;
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;
&lt;br /&gt;
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;
&lt;br /&gt;
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;
&lt;br /&gt;
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6744,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6648,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;&lt;br /&gt;DR-TB medicines are very expensive&lt;br /&gt;&lt;br /&gt;Need to improve access to DR-TB drugs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;&lt;br /&gt;The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;&lt;br /&gt;The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;&lt;br /&gt;The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;&lt;br /&gt;The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;&lt;br /&gt;Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;&lt;br /&gt;A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;&lt;br /&gt;The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;&lt;br /&gt;One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;&lt;br /&gt;Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6648,
	&#039;title&#039; =&gt; &#039;Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;
&lt;br /&gt;
DR-TB medicines are very expensive&lt;br /&gt;
&lt;br /&gt;
Need to improve access to DR-TB drugs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;
&lt;br /&gt;
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;
&lt;br /&gt;
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;
&lt;br /&gt;
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;
&lt;br /&gt;
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;
&lt;br /&gt;
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;
&lt;br /&gt;
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;
&lt;br /&gt;
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;
&lt;br /&gt;
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;
&lt;br /&gt;
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6744,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6648
$metaTitle = &#039;LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;&lt;br /&gt;DR-TB medicines are very expensive&lt;br /&gt;&lt;br /&gt;Need to improve access to DR-TB drugs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;&lt;br /&gt;The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;&lt;br /&gt;The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;&lt;br /&gt;The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;&lt;br /&gt;The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;&lt;br /&gt;Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;&lt;br /&gt;A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;&lt;br /&gt;The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;&lt;br /&gt;One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;&lt;br /&gt;Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar | Im4change.org</title>
    <meta name="description" content="
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify"><em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br /><br />DR-TB medicines are very expensive<br /><br />Need to improve access to DR-TB drugs<br /></em><br />As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br /><br />The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br /><br />The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br /><br />The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br /><br />The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br /><br />Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br /><br />&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br /><br />&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br /><br />Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br /><br />A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br /><br />&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br /><br />&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br /><br />The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br /><br />One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br /><br />Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br /><br />&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-trace').style.display = (document.getElementById('cakeErr67f8446b8c949-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f8446b8c949-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-code').style.display = (document.getElementById('cakeErr67f8446b8c949-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8446b8c949-context').style.display = (document.getElementById('cakeErr67f8446b8c949-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f8446b8c949-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f8446b8c949-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6648,
		&#039;title&#039; =&gt; &#039;Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;
&lt;br /&gt;
DR-TB medicines are very expensive&lt;br /&gt;
&lt;br /&gt;
Need to improve access to DR-TB drugs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;
&lt;br /&gt;
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;
&lt;br /&gt;
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;
&lt;br /&gt;
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;
&lt;br /&gt;
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;
&lt;br /&gt;
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;
&lt;br /&gt;
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;
&lt;br /&gt;
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;
&lt;br /&gt;
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;
&lt;br /&gt;
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6744,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6648,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;&lt;br /&gt;DR-TB medicines are very expensive&lt;br /&gt;&lt;br /&gt;Need to improve access to DR-TB drugs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;&lt;br /&gt;The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;&lt;br /&gt;The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;&lt;br /&gt;The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;&lt;br /&gt;The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;&lt;br /&gt;Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;&lt;br /&gt;A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;&lt;br /&gt;The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;&lt;br /&gt;One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;&lt;br /&gt;Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6648,
	&#039;title&#039; =&gt; &#039;Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;
&lt;br /&gt;
DR-TB medicines are very expensive&lt;br /&gt;
&lt;br /&gt;
Need to improve access to DR-TB drugs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;
&lt;br /&gt;
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;
&lt;br /&gt;
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;
&lt;br /&gt;
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;
&lt;br /&gt;
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;
&lt;br /&gt;
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;
&lt;br /&gt;
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;
&lt;br /&gt;
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;
&lt;br /&gt;
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;
&lt;br /&gt;
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6744,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6648
$metaTitle = &#039;LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB&lt;br /&gt;&lt;br /&gt;DR-TB medicines are very expensive&lt;br /&gt;&lt;br /&gt;Need to improve access to DR-TB drugs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&amp;eacute;decins Sans Fronti&amp;egrave;res (MSF).&lt;br /&gt;&lt;br /&gt;The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.&lt;br /&gt;&lt;br /&gt;The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.&lt;br /&gt;&lt;br /&gt;The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.&lt;br /&gt;&lt;br /&gt;The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.&lt;br /&gt;&lt;br /&gt;Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&amp;rdquo; said Blessina Kumar of Stop TB Partnership.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Patients have been stuck in a vicious circle &amp;ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.&lt;br /&gt;&lt;br /&gt;A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &amp;mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we&#039;re going to see many more people who will need reliable drug supplies to get treated,&amp;rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&amp;rdquo; said Ladomirska.&lt;br /&gt;&lt;br /&gt;The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.&lt;br /&gt;&lt;br /&gt;One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.&lt;br /&gt;&lt;br /&gt;Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&amp;rdquo; said Ladomirska.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar | Im4change.org</title>
    <meta name="description" content="
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify"><em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br /><br />DR-TB medicines are very expensive<br /><br />Need to improve access to DR-TB drugs<br /></em><br />As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br /><br />The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br /><br />The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br /><br />The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br /><br />The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br /><br />Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br /><br />&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br /><br />&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br /><br />Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br /><br />A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br /><br />&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br /><br />&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br /><br />The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br /><br />One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br /><br />Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br /><br />&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 6648,
		'title' => 'Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar',
		'subheading' => '',
		'description' => '<div align="justify">
<em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br />
<br />
DR-TB medicines are very expensive<br />
<br />
Need to improve access to DR-TB drugs<br />
</em><br />
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br />
<br />
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br />
<br />
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br />
<br />
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br />
<br />
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br />
<br />
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br />
<br />
&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br />
<br />
&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br />
<br />
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br />
<br />
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br />
<br />
&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br />
<br />
&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br />
<br />
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br />
<br />
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br />
<br />
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br />
<br />
&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.
</div>',
		'credit_writer' => 'The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 6744,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 6648,
	'metaTitle' => 'LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar',
	'metaKeywords' => 'Health',
	'metaDesc' => '
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...',
	'disp' => '<div align="justify"><em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br /><br />DR-TB medicines are very expensive<br /><br />Need to improve access to DR-TB drugs<br /></em><br />As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br /><br />The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br /><br />The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br /><br />The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br /><br />The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br /><br />Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br /><br />&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br /><br />&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br /><br />Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br /><br />A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br /><br />&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br /><br />&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br /><br />The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br /><br />One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br /><br />Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br /><br />&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 6648,
	'title' => 'Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar',
	'subheading' => '',
	'description' => '<div align="justify">
<em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br />
<br />
DR-TB medicines are very expensive<br />
<br />
Need to improve access to DR-TB drugs<br />
</em><br />
As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br />
<br />
The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br />
<br />
The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br />
<br />
The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br />
<br />
The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br />
<br />
Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br />
<br />
&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br />
<br />
&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br />
<br />
Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br />
<br />
A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br />
<br />
&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br />
<br />
&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br />
<br />
The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br />
<br />
One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br />
<br />
Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br />
<br />
&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.
</div>',
	'credit_writer' => 'The Hindu, 24 March, 2011, http://www.hindu.com/2011/03/24/stories/2011032455751500.htm',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'need-to-maintain-prices-supply-of-drug-resistant-tuberculosis-medicines-mdecins-sans-frontires-by-aarti-dhar-6744',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 6744,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 6648
$metaTitle = 'LATEST NEWS UPDATES | Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar'
$metaKeywords = 'Health'
$metaDesc = '
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB

DR-TB medicines are very expensive

Need to improve access to DR-TB drugs

As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO),...'
$disp = '<div align="justify"><em>As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB<br /><br />DR-TB medicines are very expensive<br /><br />Need to improve access to DR-TB drugs<br /></em><br />As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF).<br /><br />The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year.<br /><br />The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed.<br /><br />The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers.<br /><br />The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source.<br /><br />Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out.<br /><br />&ldquo;In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,&rdquo; said Blessina Kumar of Stop TB Partnership.<br /><br />&ldquo;Patients have been stuck in a vicious circle &ndash; not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.&rdquo;<br /><br />Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade.<br /><br />A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient &mdash; 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB.<br /><br />&ldquo;Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,&rdquo; said Joanna Ladomirska, Medical Coordinator for MSF in India.<br /><br />&ldquo;We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,&rdquo; said Ladomirska.<br /><br />The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems.<br /><br />One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront.<br /><br />Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down.<br /><br />&ldquo;With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,&rdquo; said Ladomirska.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar

As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB DR-TB medicines are very expensive Need to improve access to DR-TB drugs As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international medical humanitarian organisation Médecins Sans Frontières (MSF). The DR-TB is on the rise, but less than 7 per cent of 4,40,000 new cases each year receive treatment. It kills 150,000 people in the world annually, according to the WHO. India is one of the countries with the highest burden of DR-TB cases in the world, with more than 99,000 new cases each year. The MSF report, released to mark World TB Day, shows that DR-TB drugs are riddled with persistent supply and price problems that must be urgently addressed. The report examines medicines used to treat DR-TB according to the number of suppliers, quality assurance and price, based on information obtained from the Global Drug Facility and drug manufacturers. The report highlights that four of the recommended DR-TB medicines are available from only one quality-assured generic source. Relying on a sole supplier whose production could be disrupted or stopped at any time always carries a risk of dangerous treatment interruption for patients. For example, supplies of injectable drug kanamycin were disrupted in 2010, leading to a temporary global stock out. “In India and several other countries, resistance to TB drugs is a serious public health issue, which cannot be allowed to get worse,” said Blessina Kumar of Stop TB Partnership. “Patients have been stuck in a vicious circle – not enough people are diagnosed, and drug supply problems along with high prices stand in the way of putting more people on treatment.” Additionally, the MSF report found that several DR-TB medicines are very expensive, with prices for two drugs having increased by more than 600 per cent and one drug by more than 800 per cent over the last decade. A 24-month DR-TB treatment regimen can cost as much as $9,000 for one patient — 470 times more than the $19 per patient it costs to cure standard, drug-sensitive TB. “Now that we have a new test that can detect DR-TB in less than two hours instead of three months, we're going to see many more people who will need reliable drug supplies to get treated,” said Joanna Ladomirska, Medical Coordinator for MSF in India. “We need to see some immediate action to improve access to DR-TB drugs so that more people are started on treatment and transmission of this disease is reduced. This is particularly important in India, given the high burden of DR-TB here,” said Ladomirska. The low demand for DR-TB drugs had made the market unattractive for producers, which was reinforcing the supply and price problems. One way to kick start increased production of some of these drugs is for donors to guarantee purchase volumes for several years to producers upfront. Other mechanisms such as better forecasting of the mid-to long-term needs for DR-TB drugs are also needed to help attract more producers to the market, to improve supply security and increase competition that helps brings prices down. “With faster diagnosis and better treatment models of the DR-TB, we need to fix the supply and price issues with DR-TB drugs. We also need to see newer drugs developed,” said Ladomirska.